Mark Pykett

Mark Jerome Pykett was the founder of Cytomatrix, established in 1996, where the title held was President & Chief Executive Officer from 1996 to 2003.
Current jobs include Vice Chairman at Pharming Group NV starting in 2025, Chairman at Inflectis Bioscience SAS since 2021, Chairman at MyoPax GmbH, and Director at Exubrion Therapeutics, Inc. Former jobs include Chief Executive Officer & Director at Navidea Biopharmaceuticals, Inc. in 2014, President, Chief Executive Officer & Director at Agilis Biotherapeutics LLC from 2014 to 2018, President & Chief Executive Officer at Myrtelle LLC, Director at Mast Therapeutics, Inc. in 2004, Director at Health Builders International, Inc., Director at Oramax LLC from 2000 to 2006, President & Chief Operating Officer at Alseres Pharmaceuticals, Inc. from 2004 to 2010, President at CyGenics Ltd. in 2004, and President at Cordlife Group Ltd. from 2003 to 2005, and Chief Scientific Officer at PTC Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Pennsylvania, an undergraduate degree from Amherst College, an MBA from Northeastern University, and a doctorate from the University of Pennsylvania School of Veterinary Medicine.